Dear Atreyians, Namaskar!

Atreya Innovations is celebrating its 8th anniversary today, and I would like to congratulate everyone on this special occasion. The past 8 years have been a roller coaster ride full of ups and downs, but with the power of teamwork, research, innovation, trust, and excellence, we have found our path. We have gained valuable experience, strengthened our skills, achieved outstanding results, satisfied our customers, and forged numerous collaborations. Today, I humbly express my appreciation to all of our employees, clients, and partners, and share my thoughts for the upcoming year.

India, along with the rest of the world, has witnessed the challenging COVID-19 outbreak, which has caused financial and emotional turmoil. Despite these difficulties, Atreya has managed to survive, thanks to the unwavering support of our early customers, employees, mentors, and family members. This difficult period has been a valuable teacher for all of us, redefining many of our relationships and friendships.

It’s worth noting that the COVID-19 outbreak has actually resulted in a significant increase in the market size for our product, as well as a more positive mindset towards our segment among our customers. Additionally, it has opened up numerous avenues and funding opportunities in our field. Therefore, it is crucial for us to remain focused on the changing business dynamics to maintain our leadership position.

Over the last several months, receiving the National Startup Award, as well as a special mention from Hon. Modiji, and earning valuable certifications have undoubtedly boosted our comeback. With angel investments and a government grant secured, we have taken bold next steps, including receiving LOIs from three large corporations, signing MOUs with eight prestigious institutions, expanding Nadi Tarangini to two more verticals, and working towards addressing non-communicable disorders. Additionally, we have invested in innovative technologies to ensure that our product is future-ready for third-party integrations.

It has been three years since we introduced something new as COVID held us for some time, but today I am excited to make a few important announcements for the upcoming months:

First and foremost, I am pleased to announce that the Nadi Tarangini app is now available on iOS. Our team has worked diligently to develop an iOS-supported software that was long overdue. This achievement is crucial as we prepare to launch a significant project with a Europe-based corporation in June. 

It is essential to have iOS-supported and GDPR-compliant product to comply with European guidelines. With the first step successfully executed, we will now focus on ensuring compliance with these regulations.

Secondly, I am excited to announce that we will be launching Nadi Tarangini for the global market. With granted patents in Europe and Indonesia, and pending patents in other geographies, we will now expand our team and establish a presence in all seven continents.

Thirdly, I am pleased to announce that Nadi Tarangini is now available on easy EMI. With our Razorpay integration, doctors can easily make payments. Customers can enter the required details and select EMI as the payment method on the Razorpay Checkout, and then click Pay Now.

If the amount entered in the Checkout is eligible for a discount, all eligible plans provided by the card issuer will be displayed in the EMI options. This option is especially beneficial for doctors who are in the initial stages of their practice and want to provide a digital clinic experience for their patients.

Fourthly, this year, we will focus our research on the Nadi-based Diabetes monitor, which will provide a completely non-invasive and holistic way to take care of people every day. We have received a significant grant for this project and have signed MOUs with some of the best institutes in India.

We aim to gather the best researchers, diabetologists, Ayurveda experts, and statisticians to validate and create a Nadi-based continuous monitor for Diabetes. Our product will provide much more information than a blood report or a diabetes meter, and we will ensure it is simple to use and revolutionary for those who need it.

Most importantly, by the end of 2023, we will launch the high-quality specialized analytics platform ASHOKA. This intelligent platform is named after Vaidyaraj Ashok Bhat, who initiated the whole project and has given us his blessings for the journey. Nadi Tarangini and ASHOKA platform together will provide the world’s most personal and portable health monitor based on Ayurveda and data science. This innovative product will help consumers get back to a healthy, balanced lifestyle.

Any new idea takes time, and no ranking or statistics, or even what people say about us can fully reflect the true spirit that Atreya embodies. Atreya’s success lies with the people who closely engage with us. Over time, our solution has evolved from being met with skepticism to achieving nationwide adoption. You, both past and present employees, are the strength of Atreya. It is you who have built this organization, and who continue to carry it forward. FY22-23 was a good year for us, and with the new announcements mentioned above, I hope for this year to be even more fruitful. Let’s all work together and do our best!

Looking forward to our continued and happy association! Let the good times go on!

With best wishes and warm regards,

Dr. Aniruddha Joshi, CEO, Atreya Innovations

For regular updates, like and follow:

Facebook


Twitter


Youtube


Linkedin


Instagram